Online citations, reference lists, and bibliographies.
← Back to Search

Aptamer–Nanomaterial Conjugates For Medical Applications

C. Reinemann, B. Strehlitz
Published 2013 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1016/j.bios.2010.07.090
Aptamers based electrochemical biosensor for protein detection using carbon nanotubes platforms.
P. Kara (2010)
10.1039/c0nr00646g
Aptamer-conjugated nanomaterials for bioanalysis and biotechnology applications.
Tao Chen (2011)
10.1158/1535-7163.MCT-06-0172
Discovery and development of anticancer aptamers
C. Ireson (2006)
10.3390/ph4081137
Aptamer-Gated Nanoparticles for Smart Drug Delivery
V. C. Ozalp (2011)
10.1016/j.jconrel.2011.02.015
Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer.
Ronak Savla (2011)
10.1021/AC060830G
Label-free protein biosensor based on aptamer-modified carbon nanotube field-effect transistors.
K. Maehashi (2007)
10.1021/AC011052P
Detection of hydrogen peroxide at mesoporous platinum microelectrodes.
S. A. G. Evans (2002)
10.1073/pnas.1011368107
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
Nagesh Kolishetti (2010)
10.1016/J.ACA.2005.12.038
Optimization of aptamer microarray technology for multiple protein targets.
Eun Jeong Cho (2006)
10.1117/1.3465594
Direct detection of aptamer-thrombin binding via surface-enhanced Raman spectroscopy.
Cynthia V. Pagba (2010)
10.1158/0008-5472.CAN-04-2550
Nanoparticle-Aptamer Bioconjugates
O. Farokhzad (2004)
10.1021/ac801118p
Noncovalent assembly of carbon nanotubes and single-stranded DNA: an effective sensing platform for probing biomolecular interactions.
R. Yang (2008)
10.1016/j.talanta.2009.01.034
A sensitive impedimetric thrombin aptasensor based on polyamidoamine dendrimer.
Z. Zhang (2009)
Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.
S. Lupold (2002)
10.1021/AC049858N
Aptamer-based sensor arrays for the detection and quantitation of proteins.
R. Kirby (2004)
10.1021/ac8006957
Preparation of a DNA aptamer-Pt complex and its use in the colorimetric sensing of thrombin and anti-thrombin antibodies.
A. Higuchi (2008)
10.1039/c0cc00932f
Signal-on electrochemiluminescence biosensor for thrombin based on target-induced conjunction of split aptamer fragments.
Zhenyu Lin (2010)
10.1039/b910457g
A novel near-infrared protein assay based on the dissolution and aggregation of aptamer-wrapped single-walled carbon nanotubes.
H. Chen (2009)
10.1006/JCIS.1998.5985
Synthesis of Nanosize Silica in a Nonionic Water-in-Oil Microemulsion: Effects of the Water/Surfactant Molar Ratio and Ammonia Concentration.
Arriagada (1999)
10.1126/science.1125559
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
N. Rosi (2006)
10.1073/pnas.0711714105
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
F. Gu (2008)
10.1016/j.talanta.2006.09.013
Amperometric glucose biosensor based on electrodeposition of platinum nanoparticles onto covalently immobilized carbon nanotube electrode.
X. Chu (2007)
10.1021/ar900101s
Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach.
X. Fang (2010)
10.1073/PNAS.95.6.2902
High affinity ligands from in vitro selection: complex targets.
K. Morris (1998)
10.1248/BPB.33.796
Nucleolin on the cell surface as a new molecular target for gastric cancer treatment.
T. Watanabe (2010)
10.1021/ac901889s
Aptamer-nanoparticle strip biosensor for sensitive detection of cancer cells.
G. Liu (2009)
10.1002/wnan.133
Aptamers: turning the spotlight on cells.
Dalia López-Colón (2011)
10.1021/bc8001248
Aptamer-Targeted Gold Nanoparticles As Molecular-Specific Contrast Agents for Reflectance Imaging
D. Javier (2008)
10.1161/CIRCULATIONAHA.106.668434
First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology: A Phase 1a Pharmacodynamic Evaluation of a Drug-Antidote Pair for the Controlled Regulation of Factor IXa Activity
C. Dyke (2006)
10.1021/bc7003928
MRI detection of thrombin with aptamer functionalized superparamagnetic iron oxide nanoparticles.
M. V. Yigit (2008)
10.1088/0957-4484/19/41/415605
Fluorescent detection of ATP based on signaling DNA aptamer attached silica nanoparticles.
Y. Wang (2008)
10.1016/J.BIOENG.2007.06.001
SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
R. Stoltenburg (2007)
10.1038/nprot.2010.66
Development of DNA aptamers using Cell-SELEX
K. Sefah (2010)
10.1016/S0927-6513(97)00028-X
A 28-year-old synthesis of micelle-templated mesoporous silica
F. Renzo (1997)
10.1016/S1074-5521(97)90114-9
In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase.
J. Charlton (1997)
10.1021/la100139p
Anionic conjugated polymer with aptamer-functionalized silica nanoparticle for label-free naked-eye detection of lysozyme in protein mixtures.
Y. Wang (2010)
10.1016/S0968-0896(01)00028-1
Automated selection of anti-protein aptamers.
J. C. Cox (2001)
10.1038/344467A0
Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA
D. L. Robertson (1990)
10.1186/1477-3155-8-21
Laser ablation-based one-step generation and bio-functionalization of gold nanoparticles conjugated with aptamers
Johanna-Gabriela Walter (2010)
10.1166/JNN.2002.114
Development of organic dye-doped silica nanoparticles for bioanalysis and biosensors.
R. Tapec (2002)
10.1002/mabi.200900046
A hybrid DNA aptamer-dendrimer nanomaterial for targeted cell labeling.
J. Zhou (2009)
10.1016/0730-725X(88)90088-4
The effects of iron oxides on proton relaxivity.
L. Josephson (1988)
10.1021/ja0022223
Fluorescent Sensors Based on Aptamer Self-Assembly.
M. Stojanovic (2000)
10.1021/JA0038171
Aptamer-based folding fluorescent sensor for cocaine.
M. Stojanovic (2001)
10.1146/ANNUREV.BI.64.070195.003555
Diversity of oligonucleotide functions.
L. Gold (1995)
10.1039/b822836c
Self-assembly of supramolecular aptamer structures for optical or electrochemical sensing.
R. Freeman (2009)
10.1002/cmdc.200800091
Superparamagnetic Iron Oxide Nanoparticle–Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy
A. Wang (2008)
10.1016/S1084-8592(99)80014-9
The use of aptamers in large arrays for molecular diagnostics.
E. Brody (1999)
10.1373/CLINCHEM.2006.082271
Ultrasensitive densitometry detection of cytokines with nanoparticle-modified aptamers.
Yuan-Yuan Li (2007)
10.1073/PNAS.0601755103
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo.
O. Farokhzad (2006)
10.1073/pnas.2136683100
A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment
D. Daniels (2003)
10.2165/00003495-200565110-00010
Pegaptanib: in exudative age-related macular degeneration.
S. Ma (2005)
10.1517/17425240903229031
Nanoparticles for biomedical imaging
Satish K Nune (2009)
10.1021/AC035143T
Electrochemical biosensing platforms using platinum nanoparticles and carbon nanotubes.
S. Hrapovic (2004)
10.1016/S0378-4347(99)00285-6
Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide-aptamer (NX1838) in rhesus monkeys.
C. E. Tucker (1999)
10.1038/382607A0
A DNA-based method for rationally assembling nanoparticles into macroscopic materials
C. Mirkin (1996)
10.1073/pnas.0809154105
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles
Shanta Dhar (2008)
10.1021/ac702037y
Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells.
C. Medley (2008)
10.1021/BI00002A033
A DNA aptamer that binds adenosine and ATP.
D. E. Huizenga (1995)
10.1039/b712170a
Biological applications of gold nanoparticles.
Ralph A. Sperling (2008)
10.1021/jp9104618
Aptamer-based silver nanoparticles used for intracellular protein imaging and single nanoparticle spectral analysis.
L. Chen (2010)
10.1038/nbt1171
Designing dendrimers for biological applications
C. C. Lee (2005)
10.1021/AC070189Y
Selection of aptamers for molecular recognition and characterization of cancer cells.
Zhiwen Tang (2007)
10.1038/NBT0996-1112
Mirror-image RNA that binds D-adenosine
S. Klußmann (1996)
10.1016/J.CBPA.2006.03.015
Aptamer therapeutics advance.
J. F. Lee (2006)
10.1021/ac900305y
Investigations on the specificity of DNA aptamers binding to ethanolamine.
C. Reinemann (2009)
10.1021/nn901742q
Multifunctional oval-shaped gold-nanoparticle-based selective detection of breast cancer cells using simple colorimetric and highly sensitive two-photon scattering assay.
W. Lu (2010)
10.1039/b920865h
Directed evolution of gold nanoparticle delivery to cells.
N. Li (2010)
10.1021/ac200383z
Versatile electrochemiluminescence assays for cancer cells based on dendrimer/CdSe-ZnS-quantum dot nanoclusters.
G. Jie (2011)
10.1126/SCIENCE.1104274
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
X. Michalet (2005)
10.1021/nn901877h
A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer.
Dong-kyu Kim (2010)
10.1002/ADMA.200700665
Carbon Nanotubes for Electronic and Electrochemical Detection of Biomolecules.
S. Kim (2007)
10.1021/ac100812c
Magnetic nanoparticle enhanced surface plasmon resonance sensing and its application for the ultrasensitive detection of magnetic nanoparticle-enriched small molecules.
J. Wang (2010)
10.1074/mcp.M700026-MCP200
Aptamer Directly Evolved from Live Cells Recognizes Membrane Bound Immunoglobin Heavy Mu Chain in Burkitt's Lymphoma Cells*S
Prabodhika Mallikaratchy (2007)
10.1126/SCIENCE.7510417
High-resolution molecular discrimination by RNA.
R. Jenison (1994)
10.1016/1074-5521(95)90032-2
Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor.
L. Green (1995)
10.1021/AC052015R
Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells.
Joshua K Herr (2006)
10.1016/J.BIOCHI.2006.02.004
Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface.
Shoji P Ohuchi (2006)
10.1021/AC011294P
An aptamer-based quartz crystal protein biosensor.
M. Liss (2002)
10.1073/pnas.0602615103
Aptamers evolved from live cells as effective molecular probes for cancer study
Dihua Shangguan (2006)
10.1373/CLINCHEM.2006.083246
Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples.
Dihua Shangguan (2007)
10.1002/cbic.200700323
Smart “Turn‐on” Magnetic Resonance Contrast Agents Based on Aptamer‐Functionalized Superparamagnetic Iron Oxide Nanoparticles
M. V. Yigit (2007)
10.1006/ABIO.2000.4595
A fiber-optic microarray biosensor using aptamers as receptors.
M. Lee (2000)
10.1021/ja802913f
Regulation of singlet oxygen generation using single-walled carbon nanotubes.
Zhi Zhu (2008)
10.1039/b926958d
Solid-contact potentiometric aptasensor based on aptamer functionalized carbon nanotubes for the direct determination of proteins.
A. Düzgün (2010)
10.1021/JA034483T
A DNA aptamer as a new target-specific chiral selector for HPLC.
M. Michaud (2003)
10.1093/nass/nrn350
Properties of superparamagnetic iron oxide nanoparticles assembled on nucleic acids.
K. Tanaka (2008)
10.1038/355564A0
Selection of single-stranded DNA molecules that bind and inhibit human thrombin
L. C. Bock (1992)
10.1038/355850A0
Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures
A. Ellington (1992)
10.1038/346818A0
In vitro selection of RNA molecules that bind specific ligands
A. Ellington (1990)
10.1016/J.PCRYSGROW.2008.08.003
Synthesis, properties, and applications of magnetic iron oxide nanoparticles
A. Teja (2009)
10.1002/ANIE.200502589
Fast colorimetric sensing of adenosine and cocaine based on a general sensor design involving aptamers and nanoparticles.
J. Liu (2005)
10.1002/3527608192
The aptamer handbook : functional oligonucleotides and their applications
Sven. edited by Sven Klussmann. Klussmann (2006)
10.1016/j.aca.2008.05.031
Applications of aptamers in cancer cell biology.
J. Phillips (2008)
10.1345/aph.1G604
Pegaptanib: A Novel Approach to Ocular Neovascularization
J. Chapman (2006)
10.1002/ANIE.200603106
A simple and sensitive "dipstick" test in serum based on lateral flow separation of aptamer-linked nanostructures.
J. Liu (2006)
10.1021/ac8021746
Nanosensors based on viologen functionalized silver nanoparticles: few molecules surface-enhanced Raman spectroscopy detection of polycyclic aromatic hydrocarbons in interparticle hot spots.
L. Guerrini (2009)
10.1039/B707642H
Simple and sensitive aptamer-based colorimetric sensing of protein using unmodified gold nanoparticle probes.
Hui Wei (2007)
10.1021/ac901223q
Aptamer-based detection of epithelial tumor marker mucin 1 with quantum dot-based fluorescence readout.
Alan K H Cheng (2009)
10.1016/j.jviromet.2008.03.013
Application of a novel in vitro selection technique to isolate and characterise high affinity DNA aptamers binding mammalian prion proteins.
D. Bibby (2008)
10.1016/J.BIOMATERIALS.2006.09.047
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery.
J. Cheng (2007)
10.2967/jnumed.109.069880
A Nucleolin-Targeted Multimodal Nanoparticle Imaging Probe for Tracking Cancer Cells Using an Aptamer
D. Hwang (2010)
High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I.
T. Wiegand (1996)
10.1158/1535-7163.MCT-05-0361
AGRO100 inhibits activation of nuclear factor-κB (NF-κB) by forming a complex with NF-κB essential modulator (NEMO) and nucleolin
A. C. Girvan (2006)
10.1126/SCIENCE.287.5454.820
Adaptive recognition by nucleic acid aptamers.
T. Hermann (2000)
10.1002/chem.201001173
Electrochemical and electrochemiluminescence determination of cancer cells based on aptamers and magnetic beads.
Caifeng Ding (2010)
10.1021/ac103087z
New strategy for label-free and time-resolved luminescent assay of protein: conjugate Eu3+ complex and aptamer-wrapped carbon nanotubes.
X. Ouyang (2011)
10.1021/ac201442a
Detection of lysozyme magnetic relaxation switches based on aptamer-functionalized superparamagnetic nanoparticles.
S. Bamrungsap (2011)
10.1021/AC070772E
Ultrasensitive electrochemical detection of proteins by amplification of aptamer-nanoparticle bio bar codes.
P. He (2007)
10.1006/BBRC.2002.6581
Molecular aptamer beacons for real-time protein recognition.
J. Li (2002)
10.1002/smll.200801580
In vitro derby imaging of cancer biomarkers using quantum dots.
M. H. Ko (2009)
10.1039/b801055b
Ultrasensitive colorimetric detection of protein by aptamer-Au nanoparticles conjugates based on a dot-blot assay.
Y. Wang (2008)
10.1016/J.JMB.2007.05.052
Peptide aptamers expressed in the secretory pathway interfere with cellular PrPSc formation.
S. Gilch (2007)
10.1021/AC0519864
Nucleic acid-functionalized Pt nanoparticles: Catalytic labels for the amplified electrochemical detection of biomolecules.
R. Polsky (2006)
10.1021/BI961544+
Inhibitory DNA ligands to platelet-derived growth factor B-chain.
L. Green (1996)
10.1021/CR030698+
Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology.
M. Daniel (2004)
10.1126/SCIENCE.2200121
Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.
C. Tuerk (1990)
10.1016/j.bios.2009.06.016
Aptamer-Au NPs conjugates-enhanced SPR sensing for the ultrasensitive sandwich immunoassay.
J. Wang (2009)
10.1016/j.addr.2008.03.014
Multifunctional magnetic nanoparticles for targeted imaging and therapy.
J. Mccarthy (2008)
10.1177/153537020623100211
DNA Aptamers That Bind to PrPC and Not PrpSc Show Sequence and Structure Specificity
Kaori Takemura (2006)
10.1371/journal.pone.0029604
Probing the SELEX Process with Next-Generation Sequencing
T. Schütze (2011)
10.1021/la9026865
Lysine-functionalized silver nanoparticles for visual detection and separation of histidine and histidine-tagged proteins.
Doo Ri Bae (2010)
10.1021/ac9011073
Using aptamer-conjugated fluorescence resonance energy transfer nanoparticles for multiplexed cancer cell monitoring.
X. Chen (2009)
10.1021/ac101865s
Sensitive discrimination and detection of prion disease-associated isoform with a dual-aptamer strategy by developing a sandwich structure of magnetic microparticles and quantum dots.
S. Xiao (2010)
10.2174/092986711797189600
Nucleic acid aptamers: clinical applications and promising new horizons.
X. Ni (2011)
10.1016/j.ab.2008.10.043
Electrochemical DNA biosensor based on silver nanoparticles/poly(3-(3-pyridyl) acrylic acid)/carbon nanotubes modified electrode.
Y. Zhang (2009)
10.1021/AC061528A
Reusable platinum nanoparticle modified boron doped diamond microelectrodes for oxidative determination of arsenite.
S. Hrapovic (2007)
10.1021/AC050957Q
Aptamer-modified gold nanoparticles for colorimetric determination of platelet-derived growth factors and their receptors.
C. Huang (2005)
10.1159/000096085
DNA Aptamers That Bind to MUC1 Tumour Marker: Design and Characterization of MUC1-Binding Single-Stranded DNA Aptamers
C. Ferreira (2006)
10.1021/JP062536Y
Gold and silver nanoparticles in sensing and imaging: sensitivity of plasmon response to size, shape, and metal composition.
Kyeongseok Lee (2006)
10.1021/ac702322j
Cancer cell targeting using multiple aptamers conjugated on nanorods.
Y. Huang (2008)
10.1002/cbic.200500218
Quantum‐Dot Aptamer Beacons for the Detection of Proteins
M. Levy (2005)
10.2174/156802610791384207
Magnetic nanoparticles as both imaging probes and therapeutic agents.
Lise-Marie Lacroix (2010)



Semantic Scholar Logo Some data provided by SemanticScholar